Friday, July 31, 2026

AFC Women’s Champions League 2026: What to Expect from the Historic Semi-Finals

Suwon FC Women prepare for the AFC Women's ACL Semifinals, with North Korea's team participation uncertain amid heightened security.

Kim’s Back at It — North Korea Launches Missiles After 2-Month Silence

North Korea resumes ballistic missile launches, signaling military modernization and increased tensions in the region.

WAR Criminal Kim: International Court Plot Thickens—North Korea To Be HELD Accountable For Ukraine Blood

Experts at the 2025 World Conference on North Korean Human Rights call for accountability for North Korea's support of Russia in Ukraine.

Tag: dual-target therapy

Nesuparib: A Game-Changer in Cancer Treatment? Key Findings from AACR 2026

Onconic Therapeutics' Nesuparib shows promising results against small cell lung and pancreatic cancers, highlighting its competitive edge.

Nesuparib vs. Traditional Treatments: Will This New Dual-Target Cancer Drug Change the Game for Ovarian Cancer?

Onconic Therapeutics advances Nesuparib into Phase 2 trials for ovarian cancer, aiming to validate a novel re-maintenance therapy approach.

Top News

- Our Sponsors Ad -

Follow us